Sarissa Resources Inc (SRSR)

[webpence]

January 6, 2015 OTC Markets Group 304 Hudson Street 3rd Floor New York, New York 10013 Re: Attorney Letter Ladies/Gentlemen: You are entitled to rely on this letter in determining whether Sarissa Resources, Inc. (the “Issuer”) has made adequate current information publicly available within the meaning of Rule 144(c)(2) under the Securities Act of 1933. I am a resident of the United States and have been retained by the Issuer for the purpose of rendering this letter and related matters. This firm has been retained solely for the purpose of reviewing the current information supplied by the issuer. I have examined such corporate records and other documents and such questions of law as I have considered necessary or appropriate for purposes of writing this letter. In all such examinations, I have assumed the genuineness of all signatures, the authenticity of all documents submitted to me as originals, the conformity to original documents of all documents submitted to me as copies and the authenticity of all originals of such documents submitted as copies. Further, in all such examinations, I may have relied on information obtained from public officials, officers of the Issuer, and other sources, and represent that all such sources are believed to be reliable. I am authorized to practice law in the State of Utah and am a member of the Utah State Bar. This letter relates to the laws of the United States, specifically Federal securities law. I am permitted to practice before the Securities and Exchange Commission (the “SEC”) and I have not been prohibited from practice thereunder. The Issuer is not a reporting company and, therefore, does not file annual or other reports with the SEC. I have reviewed publicly available information relating to the Issuer including: (i) the Issuer’s profile posted on the OTC Markets Group’s website, (ii) the Quarterly Report Disclosure Statement filed with the OTC Markets Group on January 2, 2015, (iii) the Quarterly Report financial statements for the period ended September 30, 2014, and (iv) the 2013 Annual Financial Statements for the year ended December 31, 2013 that are publicly available through the OTC Disclosure & News Services (the “Information”). It is my opinion that the Information (i) constitutes adequate current public information concerning the Issuer’s securities and is available within the meaning of Rule 144(c)(2) under the Securities Act of 1933; (ii) includes all of the information that a broker-dealer would be required to obtain from the Issuer to publish a quotation for the Securities under Rule 15c2-11 under the Securities Exchange Act of 1934 (the “Exchange Act”); (iii) complies as to form with the OTC arkets Group’s OTC Pink Disclosure Guidelines, which are located on the Internet at www.otcmarkets.com; and (iv) has been posted through the OTC Disclosure & News Service. The person responsible for the preparation and compilation of the unaudited financial statements contained in the Information is William Andrew Campbell. Mr. Campbell is qualified to prepare the financial statements because he is a certified public accountant. The Issuer’s transfer agent is Capital Transfer Agency, Inc., which is registered with the SEC. The method used to confirm the number of outstanding shares of common stock set forth in the Information Statement was to review a current shareholder list of the Company. As of September 30, 2014 and the date of this letter, the number of shares outstanding was 923,402,453. I have personally met with management and a majority of the directors of the Issuer; I have reviewed the Information, published by the Issuer through the OTC Disclosure and News Service; and I have discussed the Information with management and a majority of the directors of the Issuer. To the best of my knowledge, after inquiry of management and the directors of the Issuer, neither, counsel nor any officer, director or 5% holder of the securities of the Issuer is currently under investigation by any federal or state regulatory authority for any violation of federal or states securities laws. No person other than the OTC Markets Group is entitled to rely on this letter. However, I hereby grant the OTC Markets Group full and complete permission and rights to publish the letter through the OTC Disclosure and News Service for viewing by the public and regulators. Very truly yours, BRUNSON CHANDLER & JONES, PLLC

http://www.otcmarkets.com/financialReportViewer?symbol=SRSR&id=131391